PDCD1 and neoplasm: One excellent example illustrating the therapeutic potential of microneedle nanotechnology is a study by Wang and colleagues who used this approach for tumor-associated anti-PD-1 antibody release in a subcutaneous B16F10 mouse melanoma model [23].